Clinical Trial Update: Study of Pembrolizumab With or Without Platinum-based Combination Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma (MK-3475-361/KEYNOTE-361) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pembrolizumab with or without platinum-based chemotherapy versus chemotherapy alone in urothelial carcinoma completed; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urothelial Carcinoma Associated 1 RNA, Human | Phase 3 | Status: COMPLETED | Results posted: 2021-05-20